Net income per share of Jazz Pharmaceuticals 2016-2023
In 2023, Jazz Pharmaceuticals reported 6.55 U.S. dollars of (basic) net income per share, a significant increase compared to the two preceding years. This statistic illustrates the net income per share of Jazz Pharmaceuticals from 2016 to 2023. Jazz Pharmaceuticals is a California-originated, but today Ireland-based biopharma company.